Staff Members - Benha University
Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway
• 2018
Publication Information
Authors
Nesrine Ebrahim 1,2, Inas A. Ahmed 3,4, Noha I. Hussien 5, Arigue A. Dessouky 6,
Ayman Samir Farid 7,*, Amal M. Elshazly 8, Ola Mostafa 1, Walaa Bayoumie El Gazzar 3,
Safwa M. Sorour 9, Yasmin Seleem 9, Ahmed M. Hussein 10 and Dina Sabry 11,12
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Diabetic nephropathy (DN) is a serious complication of diabetes mellitus
and a common cause of end-stage renal disease. Autophagy has a defensive role against kidney
damage caused by hyperglycemia. Mesenchymal stem cell (MSC)-derived exosomes are currently
considered as a new promising therapy for chronic renal injury. However, the renal-protective
mechanism of exosomes on DN is not completely understood. We examined the potential role of
MSC-derived exosomes for enhancement of autophagy activity and their effect on DN. In our study,
we used five groups of rats: control; DN; DN treated with exosomes; DN treated with 3-
methyladenine (3-MA) and chloroquine (inhibitors of autophagy); and DN treated with 3-
methyladenine (3-MA), chloroquine, and exosome groups. We assessed renal function,
morphology, and fibrosis. Moreover, ratios of the autophagy markers mechanistic target of
rapamycin (mTOR), Beclin-1, light chain-3 (LC3-II), and LC3-II/LC3-I were detected. Additionally,
electron microscopy was used for detection of autophagosomes. Results: Exosomes markedly
improved renal function and showed histological restoration of renal tissues, with significant
increase of LC3 and Beclin-1, and significant decrease of mTOR and fibrotic marker expression in
renal tissue. All previous effects were partially abolished by the autophagy inhibitors chloroquine
and a common cause of end-stage renal disease. Autophagy has a defensive role against kidney
damage caused by hyperglycemia. Mesenchymal stem cell (MSC)-derived exosomes are currently
considered as a new promising therapy for chronic renal injury. However, the renal-protective
mechanism of exosomes on DN is not completely understood. We examined the potential role of
MSC-derived exosomes for enhancement of autophagy activity and their effect on DN. In our study,
we used five groups of rats: control; DN; DN treated with exosomes; DN treated with 3-
methyladenine (3-MA) and chloroquine (inhibitors of autophagy); and DN treated with 3-
methyladenine (3-MA), chloroquine, and exosome groups. We assessed renal function,
morphology, and fibrosis. Moreover, ratios of the autophagy markers mechanistic target of
rapamycin (mTOR), Beclin-1, light chain-3 (LC3-II), and LC3-II/LC3-I were detected. Additionally,
electron microscopy was used for detection of autophagosomes. Results: Exosomes markedly
improved renal function and showed histological restoration of renal tissues, with significant
increase of LC3 and Beclin-1, and significant decrease of mTOR and fibrotic marker expression in
renal tissue. All previous effects were partially abolished by the autophagy inhibitors chloroquine